Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Healthtrust
Covington
Johnson and Johnson
McKinsey
Express Scripts
Novartis
Teva
Mallinckrodt
Cantor Fitzgerald

Generated: October 18, 2017

DrugPatentWatch Database Preview

DISULFIRAM Drug Profile

« Back to Dashboard

Which patents cover Disulfiram, and when can generic versions of Disulfiram launch?

Disulfiram is a drug marketed by Mylan Pharms Inc, Sigmapharm Labs Llc, West-ward Pharms Int, Chartwell Molecules, Watson Labs, Alvogen Malta, Watson Labs Teva, and Par Pharm. and is included in eleven NDAs.

The generic ingredient in DISULFIRAM is disulfiram. There are seven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the disulfiram profile page.

Summary for Tradename: DISULFIRAM

US Patents:0
Applicants:8
NDAs:11
Suppliers / Packagers: see list5
Bulk Api Vendors: see list77
Clinical Trials: see list48
Patent Applications: see list3,552
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DISULFIRAM at DailyMed

Pharmacology for Tradename: DISULFIRAM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Pharms Inc
DISULFIRAM
disulfiram
TABLET;ORAL203916-001Mar 4, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Chartwell Molecules
DISULFIRAM
disulfiram
TABLET;ORAL091563-001Dec 31, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Sigmapharm Labs Llc
DISULFIRAM
disulfiram
TABLET;ORAL091619-002Mar 28, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
DISULFIRAM
disulfiram
TABLET;ORAL086889-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Chartwell Molecules
DISULFIRAM
disulfiram
TABLET;ORAL091563-002Dec 31, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Par Pharm
DISULFIRAM
disulfiram
TABLET;ORAL088792-001Aug 14, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
DISULFIRAM
disulfiram
TABLET;ORAL203916-002Mar 4, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Sigmapharm Labs Llc
DISULFIRAM
disulfiram
TABLET;ORAL091619-001Mar 28, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
DISULFIRAM
disulfiram
TABLET;ORAL202652-002Feb 5, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
DISULFIRAM
disulfiram
TABLET;ORAL202652-001Feb 5, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Colorcon
Dow
Julphar
Novartis
Daiichi Sankyo
Covington
Merck
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot